Breast cancer is a leading malignancy among women globally, with chemotherapy as a cornerstone of treatment.
However, the side effects and toxicity associated with chemotherapy necessitate the exploration of adjunctive therapies to improve efficacy and reduce adverse effects.
Thymoquinone (TQ) has shown potential anti-cancer properties.
This systematic review aimed to evaluate the effectiveness of TQ in combination with chemotherapeutic agents in treating breast cancer.
